Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on Finerenone for Children with Chronic Kidney Disease and Proteinuria Using ACEI or ARB

    Not recruiting

    3 1
    Investigated Drugs:
    Austria Belgium Bulgaria Czechia Denmark Finland +11
  • Study on the Effectiveness and Safety of Finerenone for Adults with Non-Diabetic Chronic Kidney Disease

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Bulgaria Czechia Denmark Greece Hungary +3
  • Study on Reducing Protein in Urine for Patients with Chronic Kidney Disease Using Finerenone and Semaglutide

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark Italy The Netherlands Spain
  • Study on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure

    Not recruiting

    3 1 1
    Investigated Drugs:
    Belgium Bulgaria Czechia Denmark France Germany +9
  • Study on Low Dose Rivaroxaban for Heart and Blood Vessel Disease in Patients with Advanced Kidney Disease or on Dialysis

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany
  • Study on Balcinrenone and Dapagliflozin for Adults with Chronic Kidney Disease and Albuminuria

    Not recruiting

    2 1 1
    Austria Bulgaria Italy Poland Spain
  • Study on the Effect of Dapagliflozin in Reducing Proteinuria in Patients with Chronic Kidney Disease After Kidney Transplant

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study on Retatrutide and Placebo for Kidney Function in Overweight or Obese Patients with Chronic Kidney Disease, with or without Type 2 Diabetes

    Not recruiting

    2 1 1
    Investigated Drugs:
    Italy Spain
  • Study on the Effect of Patiromer on Vascular Health in Patients with Chronic Kidney Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • Evaluating Once Daily Orforglipron (LY3502970) Compared to Insulin Glargine in Adults with Type 2 Diabetes and Obesity or Overweight who Have Increased Cardiovascular Risk

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Austria Czechia Germany Greece Italy Romania +2